• search hit 1 of 1
Back to Result List

The 1027th target candidate in stroke: Will NADPH oxidase hold up?

Please always quote using this URN: urn:nbn:de:bvb:20-opus-124197
  • As recently reviewed, 1026 neuroprotective drug candidates in stroke research have all failed on their road towards validation and clinical translation, reasons being quality issues in preclinical research and publication bias. Quality control guidelines for preclinical stroke studies have now been established. However, sufficient understanding of the underlying mechanisms of neuronal death after stroke that could be possibly translated into new therapies is lacking. One exception is the hypothesis that cellular death is mediated by oxidativeAs recently reviewed, 1026 neuroprotective drug candidates in stroke research have all failed on their road towards validation and clinical translation, reasons being quality issues in preclinical research and publication bias. Quality control guidelines for preclinical stroke studies have now been established. However, sufficient understanding of the underlying mechanisms of neuronal death after stroke that could be possibly translated into new therapies is lacking. One exception is the hypothesis that cellular death is mediated by oxidative stress. Oxidative stress is defined as an excess of reactive oxygen species (ROS) derived from different possible enzymatic sources. Among these, NADPH oxidases (NOX1-5) stand out as they represent the only known enzyme family that has no other function than to produce ROS. Based on data from different NOX knockout mouse models in ischemic stroke, the most relevant isoform appears to be NOX4. Here we discuss the state-of-the-art of this target with respect to stroke and open questions that need to be addressed on the path towards clinical translation.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Kim A. Radermacher, Kirstin Wingler, Pamela Kleikers, Sebastian Altenhöfer, Johannes J. R. Hermans, Christoph Kleinschnitz, Harald H. H. W. Schmidt
URN:urn:nbn:de:bvb:20-opus-124197
Document Type:Journal article
Faculties:Medizinische Fakultät / Neurochirurgische Klinik und Poliklinik
Language:English
Parent Title (English):Experimental and Translational Stroke Medicine
Year of Completion:2012
Volume:4
Issue:11
Source:Experimental & Translational Stroke Medicine 2012, 4:11. DOI:10.1186/2040-7378-4-11
DOI:https://doi.org/10.1186/2040-7378-4-11
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 616 Krankheiten
Tag:NADPH oxidases (NOX); oxidative stress; stroke therapy
Release Date:2016/01/18
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung